2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.
Identifieur interne : 001F77 ( PubMed/Corpus ); précédent : 001F76; suivant : 001F782-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.
Auteurs : Ludovic Akonan ; Kouassi Yves Guillaume Molou ; Adjo Adohi-Krou ; Akoun Abou ; Abodou Jules TenonSource :
- Acta crystallographica. Section E, Structure reports online [ 1600-5368 ] ; 2010.
Abstract
In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.
DOI: 10.1107/S1600536810001960
PubMed: 21579857
Links to Exploration step
pubmed:21579857Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</title>
<author><name sortKey="Akonan, Ludovic" sort="Akonan, Ludovic" uniqKey="Akonan L" first="Ludovic" last="Akonan">Ludovic Akonan</name>
</author>
<author><name sortKey="Molou, Kouassi Yves Guillaume" sort="Molou, Kouassi Yves Guillaume" uniqKey="Molou K" first="Kouassi Yves Guillaume" last="Molou">Kouassi Yves Guillaume Molou</name>
</author>
<author><name sortKey="Adohi Krou, Adjo" sort="Adohi Krou, Adjo" uniqKey="Adohi Krou A" first="Adjo" last="Adohi-Krou">Adjo Adohi-Krou</name>
</author>
<author><name sortKey="Abou, Akoun" sort="Abou, Akoun" uniqKey="Abou A" first="Akoun" last="Abou">Akoun Abou</name>
</author>
<author><name sortKey="Tenon, Abodou Jules" sort="Tenon, Abodou Jules" uniqKey="Tenon A" first="Abodou Jules" last="Tenon">Abodou Jules Tenon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21579857</idno>
<idno type="pmid">21579857</idno>
<idno type="doi">10.1107/S1600536810001960</idno>
<idno type="wicri:Area/PubMed/Corpus">001F77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F77</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</title>
<author><name sortKey="Akonan, Ludovic" sort="Akonan, Ludovic" uniqKey="Akonan L" first="Ludovic" last="Akonan">Ludovic Akonan</name>
</author>
<author><name sortKey="Molou, Kouassi Yves Guillaume" sort="Molou, Kouassi Yves Guillaume" uniqKey="Molou K" first="Kouassi Yves Guillaume" last="Molou">Kouassi Yves Guillaume Molou</name>
</author>
<author><name sortKey="Adohi Krou, Adjo" sort="Adohi Krou, Adjo" uniqKey="Adohi Krou A" first="Adjo" last="Adohi-Krou">Adjo Adohi-Krou</name>
</author>
<author><name sortKey="Abou, Akoun" sort="Abou, Akoun" uniqKey="Abou A" first="Akoun" last="Abou">Akoun Abou</name>
</author>
<author><name sortKey="Tenon, Abodou Jules" sort="Tenon, Abodou Jules" uniqKey="Tenon A" first="Abodou Jules" last="Tenon">Abodou Jules Tenon</name>
</author>
</analytic>
<series><title level="j">Acta crystallographica. Section E, Structure reports online</title>
<idno type="eISSN">1600-5368</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">21579857</PMID>
<DateCompleted><Year>2011</Year>
<Month>07</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1600-5368</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>66</Volume>
<Issue>Pt 2</Issue>
<PubDate><Year>2010</Year>
<Month>Jan</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Acta crystallographica. Section E, Structure reports online</Title>
<ISOAbbreviation>Acta Crystallogr Sect E Struct Rep Online</ISOAbbreviation>
</Journal>
<ArticleTitle>2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</ArticleTitle>
<Pagination><MedlinePgn>o442</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1107/S1600536810001960</ELocationID>
<Abstract><AbstractText>In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akonan</LastName>
<ForeName>Ludovic</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Molou</LastName>
<ForeName>Kouassi Yves Guillaume</ForeName>
<Initials>KY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Adohi-Krou</LastName>
<ForeName>Adjo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Abou</LastName>
<ForeName>Akoun</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tenon</LastName>
<ForeName>Abodou Jules</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>01</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Acta Crystallogr Sect E Struct Rep Online</MedlineTA>
<NlmUniqueID>101089178</NlmUniqueID>
<ISSNLinking>1600-5368</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>12</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>01</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21579857</ArticleId>
<ArticleId IdType="doi">10.1107/S1600536810001960</ArticleId>
<ArticleId IdType="pmc">PMC2979779</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Farmaco. 2003 Jun;58(6):431-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12767382</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19171970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Pharm Bull (Tokyo). 2008 Mar;56(3):273-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18310935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arzneimittelforschung. 2004;54(1):64-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14979611</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:21579857 |texte= 2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:21579857" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |